Paid Clinical Trials Eugene

Discover 99 paid clinical trials in Eugene, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 99

Observational StudyStudents With Involved Families and Teachers

Recruiting

Sponsor:

Oregon Social Learning Center

Location:

Eugene OR

Code:

NCT05890456

Conditions

Emotional Regulation

Adolescent Behavior

Parenting

Eligibility Criteria

Sex: All

Age: 10 - 16

Healthy Volunteers: Not accepted

Interventions

Students with Involved Families and Teacher Program

Services As Usual

ABBV-383A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma

Recruiting

PHASE1

Sponsor:

TeneoOne Inc.

Location:

Eugene OR, Tacoma WA, Seattle WA, Phoenix AZshow 19 more

Code:

NCT05650632

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-383

OssiMend BAOssiMend BA in Posterolateral Instrumented Lumbar Fusion

Recruiting

Sponsor:

Collagen Matrix

Location:

Eugene OR

Code:

NCT04775537

Conditions

Spinal Disease

Degenerative Disc Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

OssiMend™ Bioactive Moldable

DB-1303/BNT323 vs. ChemotherapyA Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

Recruiting

PHASE3

Sponsor:

DualityBio Inc.

Location:

Eugene OR, Tigard OR, Sacramento CA, Salt Lake City UTshow 31 more

Code:

NCT06018337

Conditions

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DB-1303/BNT323

Capecitabine

Paclitaxel

Nab-paclitaxel

Observational StudyConversations With Caregivers About Health and Appearance

Recruiting

Sponsor:

University of Oregon

Location:

Eugene OR

Code:

NCT06843200

Conditions

Disordered Eating Behaviors

Depression

Feeding Behaviors

Parent-Child Relations

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Accepted

Interventions

Parent Group Discussion

Kamuvudine-8Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

Recruiting

PHASE1

PHASE2

Sponsor:

University of Kentucky

Location:

Eugene OR, Sioux Falls SD, Lexington KY, Roanoke VAshow 1 more

Code:

NCT06164587

Conditions

Geographic Atrophy

Age-Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

G7 Acetabular System with Vivacit-E, Longevity LinerG7 Acetabular System with Vivacit-E or Longevity Liner PMCF Study

Recruiting

Sponsor:

Zimmer Biomet

Location:

Eugene OR, Portland OR, Salt Lake City UT, Denver COshow 2 more

Code:

NCT04754087

Conditions

Total Hip Arthroplasty

Degenerative Joint Disease of Hip

Avascular Necrosis of Hip

Rheumatoid Arthritis of Hip

Osteoarthritis, Hip

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Vivacit-E and Longevity (HXLPE) Liners

Observational StudyData2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention

Recruiting

Sponsor:

Chestnut Health Systems

Location:

Eugene OR

Code:

NCT06852170

Conditions

Substance Abuse

Decision Making, Shared

Implementation Science

Decision Making

Organizations

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Co-Design Sessions (CDS)

Data products

ABBV-291Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

Recruiting

PHASE1

Sponsor:

AbbVie

Location:

Eugene OR, West Valley City UT, Austin TX, Huntersville NCshow 1 more

Code:

NCT06667687

Conditions

Non-Hodgkin's Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-291

IvonescimabClinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

Recruiting

PHASE3

Sponsor:

Summit Therapeutics

Location:

Eugene OR, Seattle WA, Spokane WA, Sacramento CAshow 39 more

Code:

NCT05899608

Conditions

Non-Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ivonescimab Injection

Pembrolizumab Injection